SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-20-016374
Filing Date
2020-08-04
Accepted
2020-08-04 06:30:53
Documents
16
Period of Report
2020-08-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tech20200731_8k.htm   iXBRL 8-K 42920
2 EXHIBIT 99.1 ex_196409.htm EX-99.1 292075
3 EXHIBIT 99.2 ex_196410.htm EX-99.2 4244
4 EXHIBIT 99.3 ex_196411.htm EX-99.3 4926
  Complete submission text file 0001437749-20-016374.txt   503878

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA tech-20200804.xsd EX-101.SCH 3699
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tech-20200804_def.xml EX-101.DEF 11585
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE tech-20200804_lab.xml EX-101.LAB 15465
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tech-20200804_pre.xml EX-101.PRE 11739
9 EXTRACTED XBRL INSTANCE DOCUMENT tech20200731_8k_htm.xml XML 2558
Mailing Address 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413
Business Address 614 MCKINLEY PL N E MINNEAPOLIS MN 55413 6123798854
BIO-TECHNE Corp (Filer) CIK: 0000842023 (see all company filings)

IRS No.: 411427402 | State of Incorp.: MN | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-17272 | Film No.: 201070869
SIC: 2836 Biological Products, (No Diagnostic Substances)